CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability.

Saved in:
Bibliographic Details
Title: CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability.
Authors: Mircetic, Jovan1,2, j.mircetic@dkfz-heidelberg.de, Camgöz, Aylin3,4,5,6,7, Abohawya, Moustafa1, Ding, Li8, Dietzel, Julia2, Tobar, Sebastián García2,9, Paszkowski‐Rogacz, Maciej8, Seidlitz, Therese9, Schmäche, Tim4,5,6,7,9, Mehnert, Marie‐Christin2, Sidorova, Olga8,10, Weitz, Jürgen4,5,6,7,9, Buchholz, Frank4,5,6,7,8, Stange, Daniel E.1,4,5,6,7,9, daniel.stange@uniklinikum-dresden.de
Source: Small Methods; Jun2023, Vol. 7 Issue 6, p1-14, 14p
Database: Applied Science & Technology Source
Description
ISSN:23669608
DOI:10.1002/smtd.202201605